StockDriftsStockDriftsTop 50 Adar1 Capital Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 9.33% | 1.39M | $155.2M | +5.82%(+76.69K) | $14.96(+867.06%) | 2026-03-31 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 6.3% | 994.1K | $104.8M | -5.25%(-55.05K) | $32.88(+300.31%) | 2026-03-31 | |
| ROIV | ROIVANT SCIENCES LTD | 5.47% | 3.29M | $91.0M | -4.17%(-143.06K) | $12.11(+190.15%) | 2026-03-31 | |
| IMVT | IMMUNOVANT INC | 4% | 2.68M | $66.5M | +7.98%(+198.04K) | $19.41(+99.87%) | 2026-03-31 | |
| SPY | STATE STR SPDR S&P 500 ETF T | 2.97% | 75.9K | $49.4M | +38.87%(+21.26K) | $632.26(+17.80%) | 2026-03-31 | |
| TERN | TERNS PHARMACEUTICALS INC | 2.9% | 914.7K | $48.2M | +68.88%(+373.08K) | $32.98(+60.54%) | 2026-03-31 | |
| CYTK | CYTOKINETICS INC | 2.51% | 632.6K | $41.7M | +17.10%(+92.39K) | $57.34(+50.83%) | 2026-03-31 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2.49% | 1.14M | $41.4M | +268.28%(+829.96K) | $40.73(+3.69%) | 2026-03-31 | |
| BOXX | EA SERIES TRUST | 2.36% | 337.1K | $39.2M | +0.00%(+0) | $106.13(+10.45%) | 2026-03-31 | |
| DNLI | DENALI THERAPEUTICS INC | 2.16% | 1.87M | $35.9M | +3490.94%(+1.82M) | $17.83(+44.84%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +61.37% | +320.24% |
| Top 20 Holdings Unweighted | +44.77% | +203.40% |
Sign up free to track Adar1 Capital Management LLC, compare funds side by side, and get alerts the moment positions change.